Full Text of SB3732 103rd General Assembly
SB3732 103RD GENERAL ASSEMBLY | | | 103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024 SB3732 Introduced 2/9/2024, by Sen. Cristina Castro SYNOPSIS AS INTRODUCED: | | 215 ILCS 200/10 | | 215 ILCS 200/50 | | 215 ILCS 200/65 | |
| Amends the Prior Authorization Reform Act. Provides that the Act applies to the program of group health benefits under the State Employees Group Insurance Act of 1971. Provides that a health insurance issuer shall not require prior authorization: where a medication is prescribed for a chronic condition, long-term condition, or mental health condition, has been prescribed for 6 months or more, or is a treatment for the clinical indication as supported by peer-reviewed medical publications; or for patients currently managed with an established treatment regimen. Removes language requiring a health insurance issuer to periodically review its prior authorization requirements and consider removal of prior authorization requirements under certain circumstances. Makes a conforming change. Effective July 1, 2024. |
| |
| | A BILL FOR |
| | | | SB3732 | | LRB103 37491 RPS 67614 b |
|
| 1 | | AN ACT concerning regulation. | 2 | | Be it enacted by the People of the State of Illinois, | 3 | | represented in the General Assembly: | 4 | | Section 5. The Prior Authorization Reform Act is amended | 5 | | by changing Sections 10, 50, and 65 as follows: | 6 | | (215 ILCS 200/10) | 7 | | Sec. 10. Applicability; scope. This Act applies to health | 8 | | insurance coverage as defined in the Illinois Health Insurance | 9 | | Portability and Accountability Act, the program of group | 10 | | health benefits under the State Employees Group Insurance Act | 11 | | of 1971, and policies issued or delivered in this State to the | 12 | | Department of Healthcare and Family Services and providing | 13 | | coverage to persons who are enrolled under Article V of the | 14 | | Illinois Public Aid Code or under the Children's Health | 15 | | Insurance Program Act, amended, delivered, issued, or renewed | 16 | | on or after the effective date of this Act, with the exception | 17 | | of employee or employer self-insured health benefit plans | 18 | | under the federal Employee Retirement Income Security Act of | 19 | | 1974, health care provided pursuant to the Workers' | 20 | | Compensation Act or the Workers' Occupational Diseases Act, | 21 | | and State, employee, unit of local government, or school | 22 | | district health plans. This Act does not diminish a health | 23 | | care plan's duties and responsibilities under other federal or |
| | | SB3732 | - 2 - | LRB103 37491 RPS 67614 b |
|
| 1 | | State law or rules promulgated thereunder. This Act is not | 2 | | intended to alter or impede the provisions of any consent | 3 | | decree or judicial order to which the State or any of its | 4 | | agencies is a party. | 5 | | (Source: P.A. 102-409, eff. 1-1-22 .) | 6 | | (215 ILCS 200/50) | 7 | | Sec. 50. Limitations on Review of prior authorization | 8 | | requirements. A health insurance issuer shall not require | 9 | | periodically review its prior authorization requirements and | 10 | | consider removal of prior authorization requirements : | 11 | | (1) where a medication is or procedure prescribed for | 12 | | a chronic condition, long-term condition, or mental health | 13 | | condition; has been prescribed for 6 months or more; is | 14 | | customary and properly indicated or is a treatment for the | 15 | | clinical indication as supported by peer-reviewed medical | 16 | | publications; or | 17 | | (2) for patients currently managed with an established | 18 | | treatment regimen. | 19 | | (Source: P.A. 102-409, eff. 1-1-22 .) | 20 | | (215 ILCS 200/65) | 21 | | Sec. 65. Length of prior authorization approval for | 22 | | treatment for chronic or long-term conditions. If a health | 23 | | insurance issuer requires a prior authorization for a | 24 | | recurring health care service or maintenance medication for |
| | | SB3732 | - 3 - | LRB103 37491 RPS 67614 b |
|
| 1 | | the treatment of a chronic or long-term condition, the | 2 | | approval shall remain valid for the lesser of 12 months from | 3 | | the date the health care professional or health care provider | 4 | | receives the prior authorization approval or the length of the | 5 | | treatment as determined by the patient's health care | 6 | | professional. This Section shall not apply to the prescription | 7 | | of benzodiazepines or Schedule II narcotic drugs, such as | 8 | | opioids. Except to the extent required by medical exceptions | 9 | | processes for prescription drugs set forth in Section 45.1 of | 10 | | the Managed Care Reform and Patient Rights Act, nothing in | 11 | | this Section shall require a policy to cover any care, | 12 | | treatment, or services for any health condition that the terms | 13 | | of coverage otherwise completely exclude from the policy's | 14 | | covered benefits without regard for whether the care, | 15 | | treatment, or services are medically necessary. | 16 | | (Source: P.A. 102-409, eff. 1-1-22 .) | 17 | | Section 99. Effective date. This Act takes effect July 1, | 18 | | 2024. |
|